2014
DOI: 10.1111/evj.12362
|View full text |Cite
|
Sign up to set email alerts
|

Atrial natriuretic peptide vs.N‐terminal‐pro‐atrial natriuretic peptide for the detection of left atrial dilatation in horses

Abstract: Atrial natriuretic peptide, but not NT-proANP, can be used to detect left atrial dilatation in horses. Atrial natriuretic peptide is less stable than NT-proANP when samples are stored at -20°C. Atrial natriuretic peptide is a more suitable biomarker of left atrial dilatation in horses than NT-proANP.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 44 publications
0
4
0
Order By: Relevance
“…Ultrasonography revealed moderate mitral valve regurgitation (MR) with a slightly dilated left atrium (LA) ( Table 1). The LA/Ao end-systolic diameter ratio was increased to 1.32 (reference value: < 1.25) (Van der Vekens et al, 2016).…”
Section: Case Historymentioning
confidence: 91%
“…Ultrasonography revealed moderate mitral valve regurgitation (MR) with a slightly dilated left atrium (LA) ( Table 1). The LA/Ao end-systolic diameter ratio was increased to 1.32 (reference value: < 1.25) (Van der Vekens et al, 2016).…”
Section: Case Historymentioning
confidence: 91%
“…Because of this, most of the research which studied plasma concentration of ANP and BNP in horses was performed using human kits (Nakagawa et al, 2019; Van Der Vekens et al, 2013). Evaluation of ANP concentration in horses using nonspecific kits demonstrated higher plasma concentration of ANP in horses with heart diseases and valvular regurgitation, especially mitral valve regurgitation, accompanied by the altered size of the left atrium and ventricle (Leroux et al, 2014; Trachsel et al, 2012, 2013, 2015; Van Der Vekens et al, 2016). However measurement of BNP in horses using kits available for another species does not show any significant differences between healthy horses and horses with cardiovascular diseases (Van Der Vekens, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…NT-pro-BNP has become the most commonly used cardiac biomarkers due to its proven superiority compared to other biomarkers [37]. In horses, other peptides like atrial natriuretic peptide (ANP), N-terminal-pro-atrial natriuretic peptide (NT-pro-ANP) or the steroid hormone aldosterone have been investigated in horses with cardiac disease but failed to be established [11, 36].…”
mentioning
confidence: 99%